# Solaris Pharma Corp - Inspection Records

Source: https://www.keypedia.com/companies/solaris-pharma-corp/2730f83a-223f-4ef6-95e1-4e3b069342ce

> Inspection records and compliance data for Solaris Pharma Corp in Bridgewater, New Jersey. Access full analysis and detailed observations.

---

## Details

- Name: Solaris Pharma Corp
- FEI Number: 3012158090
- City: Bridgewater
- State: New Jersey
- Country Name: United States
- Address Line 1: 1031 Us Hwy 202/206 Ste G-200
- Zip Code: 08807
- Business Operations: API/FDF ANALYTICAL TESTING, IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING

## Related Documents

- [483 - Solaris Pharma Corp - 2026-04-21](https://www.keypedia.com/records/483/solaris-pharma-corp/1fdd1dbe-84f4-44e9-9138-c3b74a20f81c) — source: FDA, date: April 21, 2026
- [FDA Inspection 1317052 - Solaris Pharma Corp - 2026-04-21](https://www.keypedia.com/records/fda_inspections/solaris-pharma-corp/b9f7b248-5c1f-4449-87fb-53f958ce2070) — source: FDA, date: April 21, 2026
- [483 - Solaris Pharma Corp - 2025-09-18](https://www.keypedia.com/records/483/solaris-pharma-corp/fe991640-a274-463f-a0eb-43b67bda9203) — source: FDA, date: September 18, 2025
- [FDA Inspection 1283114 - Solaris Pharma Corp - 2025-09-18](https://www.keypedia.com/records/fda_inspections/solaris-pharma-corp/21c2d32d-4377-4be5-8382-b321a855a9ae) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 18, 2025
- [FDA Inspection 1283114 - Solaris Pharma Corp - 2025-09-18](https://www.keypedia.com/records/fda_inspections/solaris-pharma-corp/a78a33e0-bed5-43f4-8243-b3dddf80fd56) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 18, 2025
- [FDA Inspection 1117923 - Solaris Pharma Corp - 2020-01-09](https://www.keypedia.com/records/fda_inspections/solaris-pharma-corp/84366ff4-2f07-49eb-89c5-e3009928fbd2) — classification: No Action Indicated (NAI), source: FDA, date: January 9, 2020
- [483 - Solaris Pharma Corp - 2019-10-31](https://www.keypedia.com/records/483/solaris-pharma-corp/e583753a-c336-463d-90cf-63c98c7a3038) — source: FDA, date: October 31, 2019

## Related Companies

- [Lexamed, Ltd](https://www.keypedia.com/companies/lexamed-ltd/b54f148c-75ae-4ec5-aee3-d675b90f3f88)
- [PPD Development, L.P.](https://www.keypedia.com/companies/ppd-development-lp/c8b3d3b0-5856-4714-bc30-21345649d782)
- [Primera Analytical Solutions Corp.](https://www.keypedia.com/companies/primera-analytical-solutions-corp/ebb79960-5890-48cc-a980-6b7cfe02aad4)
- [Micron Inc](https://www.keypedia.com/companies/micron-inc/a65b7d60-a630-4106-a66e-0871c2852be4)
- [PPD Development, L.P.](https://www.keypedia.com/companies/ppd-development-lp/0d495b78-4879-42fc-8887-4e0294e69720)
- [Primera Analytical Solutions Corp.](https://www.keypedia.com/companies/primera-analytical-solutions-corp/c4729b68-8ba6-46a7-a7b8-852f38c6625f)
- [Analytical Food Laboratories Inc.](https://www.keypedia.com/companies/analytical-food-laboratories-inc/05f0b77b-4efa-4d07-b01e-a8084d84b2e2)
- [Eagle Analytical Services, Inc.](https://www.keypedia.com/companies/eagle-analytical-services-inc/71dcd7b7-dc89-4b02-8f2a-1c80300abf01)
- [Samsung Bioepis Co., Ltd.](https://www.keypedia.com/companies/samsung-bioepis-co-ltd/6473332d-84de-441c-82fe-4034d7383d5e)
- [Element Materials Technology Oakland-Concord](https://www.keypedia.com/companies/element-materials-technology-oakland-concord/30d36985-08bf-4bba-865d-c40e43e3f574)

## Related Officers

- [Logman A Mohamed](https://www.keypedia.com/people/logman-a-mohamed/9c1dc6f7-1ded-4dfb-b7e6-79a58547e6c6)
- [Vvesna C Blaise](https://www.keypedia.com/people/vvesna-c-blaise/fe5a2321-1072-48f1-ba45-7afda6352a0a)
- [Brandy D. Brown](https://www.keypedia.com/people/brandy-d-brown/667c6b9a-6ab9-42d4-b364-a96207bca072)
- [Adetutu M. Gidado](https://www.keypedia.com/people/adetutu-m-gidado/6c4e8cf3-0eea-4903-9ca5-e8e2d683621d)